But new research suggests that a simple blood test may be able to predict osteoporosis risk, allowing doctors to intervene ...

Although there are several effective anti-osteoporosis drugs on the market today, new therapies with improved safety profiles and efficacy are still needed. The FDA called osteoporosis-related ...

Boston-based Beth Israel Deaconess Medical Center played a role in a new FDA decision that allows bone mineral density, measured through noninvasive imaging, to serve as a qualified endpoint in ...

Published results showed umbilical cord-derived platelet-rich plasma provided better short-term pain relief but similar ...